SEC Comment Letter for Oruka Therapeutics, Inc. (ORKA) (CIK 0000907654) (ORKA) — Dec 22, 2010

Oruka Therapeutics, Inc. (ORKA) (CIK 0000907654)
Date: Dec. 22, 2010 · CIK: 0000907654 · Accession: 0000000000-10-076848

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 000-22873

Date

December 22, 2010

Author

Joel Parker

Form

UPLOAD

Company

Oruka Therapeutics, Inc. (ORKA) (CIK 0000907654)

Letter

December 22, 2010 Patrick M. Wheeler Chief Financial Officer ARCA biopharma, Inc. 8001 Arisra Place, Suite 200 Broomfiled, CO 80021 Re: ARCA biopharma, Inc. Form 10-K for Fiscal Year Ended December 31, 2009 Filed March 4, 2010 File No. 000-22873

Dear Mr. Wheeler: We have completed our review of your Form 10-K and have no further comments at this time. S i n c e r e l y , J o e l P a r k e r A c c o u n t i n g B r a n c h C h i e f

Show Raw Text

December 22, 2010
 Patrick M. Wheeler Chief Financial Officer ARCA biopharma, Inc. 8001 Arisra Place, Suite 200 Broomfiled, CO  80021
Re: ARCA biopharma, Inc.
 Form 10-K for Fiscal Year Ended December 31, 2009
  Filed March 4, 2010
File No.  000-22873

Dear Mr. Wheeler:
 We have completed our review of your Form 10-K and have no further comments at this
time.           S i n c e r e l y ,             J o e l  P a r k e r          A c c o u n t i n g  B r a n c h  C h i e f

SecProbe.io